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TO THE EDITOR
The homing ability of hematopoietic
stem cells has enabled their therapeutic
use. We have previously shown in
allogeneic hematopoietic stem-cell
recipients that donor-derived cells can
be detected in skin in acute graft-versus-
host disease (Murata et al., 2007) and
in squamous cell carcinoma (SCC) of
the oral mucosa (Janin et al., 2009). In
kidney transplant recipients, population-
based studies show an increased risk
of skin SCC (Moloney et al., 2006;
Wisgerhof et al., 2010), which are remar-
kable for: (i) their incidence, 250 times
higher than in the normal population
(Mackenzie et al., 2010), (ii) their pre-
valence over basal cell carcinoma, (iii)
the fact that they are multiple, and (iv) their
association with multiple actinic keratosis
(AK). Donor-derived cells have been iden-
tified in one case of basal cell carcinoma
(Aractingi et al., 2005). Here we address
the question of the presence of donor-
derived cells in skin SCC and in associated
AK in kidney transplant recipients.
In three patients with AK and SCC
who had received sex-mismatched kid-
ney transplants, and for whom remain-
ing tissue samples and DNA from
donor and recipient were available, we
conducted a chimerism study using four
independent methods, FISH for X and
Y chromosome detection, ZFYqPCR,
polymorphic microsatellite analyses, and
HRM on mitochondrial DNA (Supple-
mentary Data online). The study was
approved by the Institutional Review
Board of Hoˆpital Saint-Louis (Paris,
France) and written informed consent
was obtained according to the Helsinki
Declaration.
AK and SCC lesions included in this
study were not contiguous, but 5 to
10 cm apart.
XY-FISH combined with cytokeratin
on the same tissue section showed
cytokeratin-positive cells with the donor
genotype in two female recipients of
male kidney transplants. The percentage
of chimeric cells was 4% in the SCC and
2% in the two AKs studied for Patient 1
(Figure 1a), and 5% in the SCC and
3 and 0% in the two AKs studied for
Patient 2 (Table 1). Chimeric XY cells
were distributed in the basal layer in AK
and in the basal layer and the invasive
areas in SCC. No chimeric cell was
found in normal surrounding skin. The
third patient with sex-mismatched
kidney transplant (Patient 3) was male,
and no chimeric XX cytokeratin-positive
cell was found in his SCC or AK.
As donor-derived cells were only found
in female recipients of male kidney
transplants, we performed a qPCR for
ZFY gene on AK and SCC tissue sec-
tions, which confirmed the presence of
the Y chromosome in Patient 1 SCC and
two AKs (Figure 1b) and Patient 2 SCC
and one of the two AKs studied.
To check these chromosomal results
using completely different methods,
which also associated molecular
markers and morphological selection
of cell populations, we performed
microsatellite PCR and HRM analyses
on laser-microdissected cells. Laser
microdissection, performed on tissue
sections after immunostaining of inflam-
matory cells, enabled us to collect only
keratinocytes from the basal layer in
AK and keratinocytes from the basal
layer and from invasive areas in the
dermis in SCC (Figure 1c). The poly-
morphic microsatellite marker analyses
performed on laser-microdissected cells
confirmed the presence of cells of
donor origin in the SCC and two AKs
of Patient 1, using four different
dinucleotide repeats: D3S3611,
D5S2095, D8S1820, and D9S162 (as
shown for D3S3611 in Figure 1d). It also
confirmed the presence of cells of donor
origin in the SCC and one AK of
Patient 2, using three different dinucleo-
tide repeats: D3S1597, D5S2095, and
D8S1820. Polymorphic microsatellite
analyses D3S3611, D8S1820, and
D17S1879 showed recipient origin for
Patient 3 SCC and AK.
We performed mitochondrial DNA
HRM in the same samples of laser-
microdissected keratinocytes from AK
and SCC. This second independent
method also showed the presence of
cells of donor origin in the SCC and
two AKs of Patient 1 (Figure 1e), and in
the SCC and one AK of Patient 2. The
cells of the SCC and AK of Patient 3
were all of recipient origin.
Altogether, we provide conclusive
evidence for the presence of donor-
derived basal keratinocytes in AK, and
of donor-derived basal and invasive
keratinocytes in skin SCC in two kidney
transplant recipients.
These data imply the homing of stem/
progenitor cells from the kidney trans-
plants to the recipients’ skin. For the
homing of stem/progenitor cells from
adult kidney to the skin, no experimental
data are available. Multipotent progenitor
cells from Bowman’s capsule in adult
human kidney have been isolated and
characterized (Sagrinati et al., 2006), but
a transfer of mesenchymal stem cells with
the transplant cannot be excluded.
Using combined XY-FISH and immu-
nostaining on whole tissue sections
enabled us to observe that chimeric cells
were only present in SCC and AK, and
not in normal peripheral skin. In addi-
tion, the donor-derived cells we identi-
fied in SCC were located in the basal
layer and in invasive areas, which cor-
respond to the ‘‘outer proliferating layer’’
where tumor-initiating cells have recentlyAbbreviations: AK, actinic keratosis; SCC, squamous cell carcinoma
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been characterized in skin SCC (Patel
et al., 2012). We also identified donor-
derived cells in the basal layer of AK,
which is usually considered as a benign
disease, although molecular studies have
shown frequent loss of heterozygozity
(Rehman et al., 1994) and gene
expression patterns are in favor of a
spectrum of disease progression from
normal human skin to AK and SCC
(Padilla et al., 2010). In our cases, the
concentration of chimeric cells in AK
and SCC could be linked to the tissue
remodeling accompanying disease
progression, as stem/progenitor cells are
recruited to the sites of skin injuries in
experimental conditions (Zong et al.,
2008), and tissue repair shares common
mechanisms with stem-cell renewal in
carcinogenesis (Beachy et al., 2004). In
the kidney transplant recipients we
studied, the precise role of chimeric
stem cells in skin SCC oncogenesis
remains to be established, but the
detection of chimeric cells at the stage
of AK is in favor of a multistep process in
the disease progression.
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Figure 1. Cells of same donor origin in AK and SCC in Patient 1. (a) Using FISH-XY, cytokeratin-positive basal cells with an X (green) Y (red) genotype are detected
in AK and SCC. Scale bars¼ 10mm. (b) PCR detects Y chromosome in the two AKs and SCCs of the female recipient. (c) Laser microdissection of CD45-negative
basal and invasive cells in SCC. Arrows: CD45-positive cells. Scale bars¼ 100mm. (d) Comparison of DNA profiles from laser-microdissected keratinocytes from
AK and SCC with donor and recipient normal cells. Microsatellite analysis at D3S3611 locus shows donor origin (base-pair 122 and base-pair 126) of the
microdissected keratinocytes from the two AKs and the SCCs. (e) Mitochondrial DNA-HRM PCR shows similar profiles for laser-microdissected keratinocytes of the
two AKs and SCCs, and for donor cells.
L Verneuil et al.
Donor-Derived Keratinocytes in AK and SCC
www.jidonline.org 1109
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
Grants were received from Re´gion-Ile-de-France,
Cance´ropoˆle Ile-de-France, INCa, and ANR. LV is
a Socie´te´-Franc¸aise-Dermatologie grant recipient.
A. Swaine assisted with language editing.
Laurence Verneuil1,2,3,4,
Mariana Varna1,2,5, Christophe Leboeuf1,2,
Louis Franc¸ois Plassa6,
Morad Elbouchtaoui1,2,5,
Irmine Loisel-Ferreira1,2,5,
Fatiha Bouhidel1,2,5,
Marie-Noelle Peraldi2,7, Celeste Lebbe´2,8,
Philippe Ratajczak1,2 and Anne Janin1,2,5
1Inserm U728, Paris, France; 2Laboratoire de
Pathologie, UMR-S 728, Universite´ Paris
Diderot, Sorbonne Paris Cite´, Paris, France;
3Department of Dermatology, CHU Caen,
Caen, France; 4Universite´ de Caen Basse-
Normandie Medical School, Caen, France;
5Department of Pathology, Hoˆpital Saint-Louis,
AP-HP, Paris, France; 6Department of
Biochemistry, Hoˆpital Saint-Louis, AP-HP,
Paris, France; 7Department of Nephrology,
Hoˆpital Saint-Louis, AP-HP, Paris, France and
8Department of Dermatology, Hoˆpital Saint-
Louis, AP-HP, Paris, France
E-mail: verneuil-l@chu-caen.fr or
anne.janin728@gmail.com
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Aractingi S, Kanitakis J, Euvrard S et al. (2005) Skin
carcinoma arising from donor cells in a kidney
transplant recipient. Cancer Res 65:1755–60
Beachy PA, Karhadkar SS, Berman DM (2004)
Tissue repair and stem cell renewal in
carcinogenesis. Nature 432:324–31
Janin A, Murata H, Leboeuf C et al. (2009) Donor-
derived oral squamous cell carcinoma after
allogeneic bone marrow transplantation.
Blood 113:1834–40
Mackenzie KA, Wells JE, Lynn KL et al. (2010) First
and subsequent nonmelanoma skin cancers:
incidence and predictors in a population of
New Zealand renal transplant recipients.
Nephrol Dial Transplant 25:300–6
Moloney FJ, Comber H, O’Lorcain P et al. (2006)
A population-based study of skin cancer
incidence and prevalence in renal transplant
recipients. Br J Dermatol 154:498–504
Murata H, Janin A, Leboeuf C et al. (2007) Donor-
derived cells and human graft-versus-host
disease of the skin. Blood 109:2663–5
Padilla RS, Sebastian S, Jiang Z et al. (2010)
Gene expression patterns of normal human
skin, actinic keratosis, and squamous cell
carcinoma: a spectrum of disease progression.
Arch Dermatol 146:288–93
Patel GK, Yee CL, Terunuma A et al. (2012)
Identification and characterization of
tumor-initiating cells in human primary
cutaneous squamous cell carcinoma. J Invest
Dermatol 132:401–9
Rehman I, Quinn AG, Healy E et al. (1994)
High frequency of loss of heterozygosity in
actinic keratoses, a usually benign disease.
Lancet 344:788–9
Table 1. XY-FISH data in AK and SCC of three sex-mismatched kidney transplant recipients
Sex Kidney transplantation Skin tumor XY FISH
Recipient/
donor
Age at transplant
(years)
Timelapse transplant–
tumor (years)
Site Type Keratinocytes from basal
and suprabasal layers
XX XY Total
XX
cells, %
XY
cells, %
% Chimeric cells,
corrected1
Patients with skin tumor after sex-mismatched kidney transplant XY cells
1 F/M 43 14 Forehead SCC 66 4 107 61.7 3.7 5.9
12 Forehead AK 82 2 121 67.8 1.7 2.3
12 Cheek AK 68 2 117 58.1 1.7 2.4
2 F/M 46 3 Neck SCC 60 5 98 61.2 5.1 8.1
3 Neck AK 88 3 132 66.7 2.3 3.3
1 Neck AK 95 0 141 67.4 0.0 0
XX cells
3 M/F 59 5 Nose SCC 0 71 119 0.0 59.7 0
4 Nose AK 0 61 94 0.0 64.9 0
Patient with skin tumor after sex-matched kidney transplantation
M/M 43 7 Forehead SCC 0 52 91 0.0 57.1
7 Forehead AK 0 66 109 0.0 60.6
Patients with skin tumor without kidney transplantation (control)
M Nose SCC 0 79 127 0.0 62.2
Cheek AK 0 102 147 0.0 69.4
M Leg SCC 0 72 112 0.0 64.3
Leg AK 0 101 141 0.0 71.6
1Tumor samples from two patients with SCC and AK without kidney tranplantation setting (control) were examined. To determine the efficiency of sex
chromosome detection in basal and suprabasal layers of SCC and AK, a FISH-XY protocol was applied. Tumor sections from the two patients with SCC and AK
were analyzed and the percent detection averaged for either SCC {((79:127)þ (72:112)x100):2¼63.25%} or AK {((102:147)þ (101:141)x100):2¼70.5%}. The
normalization factor was derived by dividing 100% by the average percent for either SCC (100:63.25¼ 1.58) or AK (100:70.5¼ 1.42). Here the normalization
factor was 1.42 and 1.58 for XX and XY cells detections of AK and SCC, respectively.
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TO THE EDITOR
Neutrophilic dermatoses (NDs) are char-
acterized by dense infiltrates of mature
neutrophils typically located in the
upper dermis. Despite having dissimilar
clinical presentations, Sweet’s syn-
drome, pyoderma gangrenosum, neutro-
philic eccrine hidradenitis, and other
related disorders are recognized as part
of the spectrum of NDs because of their
overlapping clinical and histopatho-
logical findings (Vignon-Pennamen
and Wallach, 1991). Although most
instances of ND have a benign course,
some extracutaneous localizations
of the neutrophilic infiltrates can be
potentially life-threatening (Vignon-
Pennamen, 2000).
Little is known about the patho-
physiology of ND. The findings of high
CD3, IL-1, IL-8, and tumor necrosis
factor-a expressions by immunohisto-
chemical staining in the dermis of ND
patients (Marzano et al., 2010) and the
impressive effects of corticosteroids in
alleviating these diseases have under-
lined a role for activated T lymphocytes
in the recruitment of mature neutrophils
to the dermis. Moreover, targeted immu-
nosuppressive agents such as tumor
necrosis factor-a inhibitors and the
IL-1R inhibitor anakinra have been
successfully used in the treatment of
Sweet’s syndrome, which has further
emphasized the importance of these
cytokines in the pathophysiology of
ND (Yamauchi et al., 2006; Delluc
et al., 2008; Lipsker et al., 2010).
Around 20% of patients with
Sweet’s syndrome have an underlying
hematological malignancy, which is
predominantly a myeloid neoplasm
(Cohen et al., 1988). In these cases,
one could hypothesize that neutrophils
have differentiated from the malignant
clone, showing an aberrant phenotype,
which promotes dermal invasion. In this
model, neutrophils in the dermal
infiltrate should be clonally related to
the underlying myeloid malignancy,
which has never been formally demon-
strated to date.
We thus conducted a multicentric
retrospective study, which included 14
ND patients (8 men and 6 women)
with (1) a histopathological diagnosis
of Sweet’s syndrome (n¼ 12), pyoderma
gangrenosum (n¼1), or neutrophilic
eccrine hidradenitis (n¼ 1), and (2) a
diagnosis of myelodysplastic syndrome
(MDS, n¼2) or acute myeloid leukemia
(AML, n¼12), and with a medullar
cytogenetic abnormality that would
be informative in a fluorescent in situ
hybridization (FISH) study.
In two patients, the ND was present at
the initial presentation of AML. This
condition was chemotherapy-induced
in seven patients and occurred without
any identifiable trigger in four patients.
All patients but one were febrile when
the ND diagnosis was established, and
four patients had an extracutaneous
involvement (lung (n¼1), muscle
(n¼ 1), mouth (n¼ 2)), which is a much
higher frequency than what is reported
in idiopathic ND (Vignon-Pennamen,
2000). No patient had concomitant
neutrophil leukocytosis. Three patients
were profoundly neutropenic at the time
of ND occurrence. This observation
confirms that hyperleukocytosis is irrele-
vant as a diagnostic criterion for ND
associated with myeloid malignancies.
To test the hypothesis of a clonal
relationship between the skin-infiltrating
neutrophils and the bone marrow blasts,
the FISH study was conducted on 3mm
skin tissue sections processed using the
Histology FISH Accessory Kit (Dako,
Glostrup, Denmark). After hybridization
with specific probes (Table 1), scoring of
the hybridization signals was performed
on 200 consecutive morphologically
intact nuclei, with a normal cutoff value
evaluated at 10% (Haralambieva et al.,
2002). This approach was noninforma-
tive in three patients because of an
insufficient number of analyzable
nuclei. Among the other 11 patients
analyzed, 8 showed the same cyto-
genetic anomaly in the neutrophils infil-
trating the skin and in the bone marrow
(Figure 1), whereas there were no
evidence of any clonal cytogenetic
abnormality in the neutrophils of the
remaining three patients.
A previous study using a HUMARA
assay has found evidence of clonality in
the skin neutrophils of 80% of women
(median age 60 years) with ND, regard-
less of whether they had an underlying
Abbreviation: AML, acute myeloid leukemia; FISH, fluorescent in situ hybridization; MDS, myelodysplastic
syndrome; ND, neutrophilic dermatosis
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